Literature DB >> 29358288

FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility.

Sumanun Suwunnakorn1, Hironao Wakabayashi1, Milena Kordalewska2, David S Perlin2, Elena Rustchenko3.   

Abstract

Candida albicans, a prevailing opportunistic fungal pathogen of humans, has a diploid genome containing three homologous FKS genes that are evolutionarily conserved. One of these, the essential gene FKS1, encodes the catalytic subunit of glucan synthase, which is the target of echinocandin drugs and also serves as a site of drug resistance. The other two glucan synthase-encoding genes, FKS2 and FKS3, are also expressed, but their roles in resistance are considered unimportant. However, we report here that expression of FKS1 is upregulated in strains lacking either FKS2 or FKS3 Furthermore, in contrast to what is observed in heterozygous FKS1 deletion strains, cells lacking FKS2 or FKS3 contain increased amounts of cell wall glucan, are more resistant to echinocandin drugs, and consistently are tolerant to cell wall-damaging agents. Our data indicate that C. albicansFKS2 and FKS3 can act as negative regulators of FKS1, thereby influencing echinocandin susceptibility.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Candida albicans; FKS genes; echinocandins; transcriptional regulation

Mesh:

Substances:

Year:  2018        PMID: 29358288      PMCID: PMC5913916          DOI: 10.1128/AAC.02299-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling.

Authors:  Cristina Reinoso-Martín; Christoph Schüller; Manuela Schuetzer-Muehlbauer; Karl Kuchler
Journal:  Eukaryot Cell       Date:  2003-12

2.  Getting started with yeast.

Authors:  Fred Sherman
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

3.  Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans.

Authors:  V Perepnikhatka; F J Fischer; M Niimi; R A Baker; R D Cannon; Y K Wang; F Sherman; E Rustchenko
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

4.  CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species.

Authors:  Junqing Shen; Weihui Guo; Julia R Köhler
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis.

Authors:  M Kretschmar; B Hube; T Bertsch; D Sanglard; R Merker; M Schröder; H Hof; T Nichterlein
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination.

Authors:  J Morschhäuser; S Michel; P Staib
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

7.  5-Fluoro-orotic acid induces chromosome alterations in Candida albicans.

Authors:  Melanie Wellington; Elena Rustchenko
Journal:  Yeast       Date:  2005-01-15       Impact factor: 3.239

Review 8.  Dynamics of cell wall structure in Saccharomyces cerevisiae.

Authors:  Frans M Klis; Pieternella Mol; Klaas Hellingwerf; Stanley Brul
Journal:  FEMS Microbiol Rev       Date:  2002-08       Impact factor: 16.408

9.  Role of the 14-3-3 protein in carbon metabolism of the pathogenic yeast Candida albicans.

Authors:  Ying-Kai Wang; Biswadip Das; David H Huber; Melanie Wellington; M Anaul Kabir; Fred Sherman; Elena Rustchenko
Journal:  Yeast       Date:  2004-06       Impact factor: 3.239

10.  Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin.

Authors:  Guillaume Lesage; Anne-Marie Sdicu; Patrice Ménard; Jesse Shapiro; Shamiza Hussein; Howard Bussey
Journal:  Genetics       Date:  2004-05       Impact factor: 4.562

View more
  15 in total

Review 1.  Antifungal Resistance: a Concerning Trend for the Present and Future.

Authors:  Joshua A Hendrickson; Chenlin Hu; Samuel L Aitken; Nicholas Beyda
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

2.  Ketoconazole resistant Candida albicans is sensitive to a wireless electroceutical wound care dressing.

Authors:  Dolly K Khona; Sashwati Roy; Subhadip Ghatak; Kaixiang Huang; Gargi Jagdale; Lane A Baker; Chandan K Sen
Journal:  Bioelectrochemistry       Date:  2021-08-04       Impact factor: 5.373

Review 3.  Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.

Authors:  Francine Perrine-Walker
Journal:  Braz J Microbiol       Date:  2022-03-29       Impact factor: 2.214

Review 4.  Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

Authors:  Yunjin Lee; Emily Puumala; Nicole Robbins; Leah E Cowen
Journal:  Chem Rev       Date:  2020-05-22       Impact factor: 60.622

Review 5.  What 'Omics can tell us about antifungal adaptation.

Authors:  Gabriela Fior Ribeiro; Eszter Denes; Helen Heaney; Delma S Childers
Journal:  FEMS Yeast Res       Date:  2022-01-11       Impact factor: 2.923

6.  The Fungal Histone Acetyl Transferase Gcn5 Controls Virulence of the Human Pathogen Candida albicans through Multiple Pathways.

Authors:  Raju Shivarathri; Michael Tscherner; Florian Zwolanek; Nitesh Kumar Singh; Neeraj Chauhan; Karl Kuchler
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

7.  Resistance to Echinocandins Complicates a Case of Candida albicans Bloodstream Infection: A Case Report.

Authors:  Laura Trovato; Dafne Bongiorno; Maddalena Calvo; Giuseppe Migliorisi; Albino Boraccino; Nicolò Musso; Salvatore Oliveri; Stefania Stefani; Guido Scalia
Journal:  J Fungi (Basel)       Date:  2021-05-21

Review 8.  Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.

Authors:  Nilce M Martinez-Rossi; Tamires A Bitencourt; Nalu T A Peres; Elza A S Lang; Eriston V Gomes; Natalia R Quaresemin; Maíra P Martins; Lucia Lopes; Antonio Rossi
Journal:  Front Microbiol       Date:  2018-05-29       Impact factor: 5.640

Review 9.  Review on Current Status of Echinocandins Use.

Authors:  Martyna Mroczyńska; Anna Brillowska-Dąbrowska
Journal:  Antibiotics (Basel)       Date:  2020-05-02

Review 10.  Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata.

Authors:  Kelley R Healey; David S Perlin
Journal:  J Fungi (Basel)       Date:  2018-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.